PPARG and neoplasm: Vallée, et al. demonstrated that non-steroidal anti-inflammatory drugs acting as PPARγ agonists help regulate the WNT/β-catenin pathway and thus control tumor growth through cell cycle arrest, cell differentiation, and apoptosis and may reduce inflammation, oxidative stress, proliferation, invasion, and cell migration [176].